慢性肝病患者血小板聚集功能测定及其临床意义

徐葆元; 刘祥贵; 方发玲; 徐建业; 周明贵; 何生玉; 张自新

doi:10.13406/j.cnki.cyxb.1986.04.001

您当前的位置：

首页 >

文章列表页 >

慢性肝病患者血小板聚集功能测定及其临床意义

更新时间：2024-01-17

- 慢性肝病患者血小板聚集功能测定及其临床意义
- THE CLINICAL SIGNIFICANCE OF BLOOD PLATELET AGGREGATION FUNCTION IN PATIENTS WITH CHRONIC LIVER DISEASE
- 重庆医科大学学报 1986年第4期页码：229-232
- 作者机构：
  
  重庆医科大学第二医院内科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.1986.04.001
  中图分类号：
- 纸质出版日期：1986，
扫描看全文
[1]徐葆元,刘祥贵,方发玲,徐建业,周明贵,何生玉,张自新.慢性肝病患者血小板聚集功能测定及其临床意义[J].重庆医科大学学报,1986(04):229-232.

THE CLINICAL SIGNIFICANCE OF BLOOD PLATELET AGGREGATION FUNCTION IN PATIENTS WITH CHRONIC LIVER DISEASE[J]. Journal of Chongqing Medical University, 1986,(4):229-232.
[1]徐葆元,刘祥贵,方发玲,徐建业,周明贵,何生玉,张自新.慢性肝病患者血小板聚集功能测定及其临床意义[J].重庆医科大学学报,1986(04):229-232. DOI： 10.13406/j.cnki.cyxb.1986.04.001.

THE CLINICAL SIGNIFICANCE OF BLOOD PLATELET AGGREGATION FUNCTION IN PATIENTS WITH CHRONIC LIVER DISEASE[J]. Journal of Chongqing Medical University, 1986,(4):229-232. DOI： 10.13406/j.cnki.cyxb.1986.04.001.

摘要

本文报告60例慢性肝病患者APP诱导的血小板聚集（PAR）功能、ADP诱导的血小板聚集交叉研究及有关凝血象测定。发现慢性肝病时PAR下降与血小板第3因子有效性异常者延长的秒数呈负相关

与病情严重性相一致

可作为肝硬化代偿与失代偿的参考指标。用血小板聚集交叉试验检测20例慢性肝病患者

发现ADP诱导血小板聚集功能低下的原因是血浆因素及血小板因素两者兼而有之。

Abstract

ADP-induced blood platelet aggregation function (PAR)

and the related blood coagulation picture were measured in 60 patients with chronic liver disease. Oar study showed that the decreased PAR was correlated negatively with the defects in platelet factor 3 availability

but was consistantly correlated with severity of the disease process

we suggested that PAR can be used as a reference index in the differentiation of compensation and decompensation between patients with liver cirrhosis. ADP-induced blood platelet aggregation cross study was measured in 20 patients with chronic liver disease and it was found that the cause of decreased PAR was due both to plasma factor and blood platelet factor

关键词

ADP诱导的血小板聚集功能（PAR）聚集强度聚集速率ADP诱导的血小板交叉试验血小板第3因子有效性

Keywords

references

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据